Prof Garcia-Manero speaks with ecancertv at ASH 2016 about the value of including patients in clinical trials who would be otherwise deselected based on potentially unrelated criteria.

He questions the barriers to enrollment of patients, quoting exploratory 'anti-trials' of patients with confounding mental illness whose clinical utility and treatment response was equal to 'fit' participants.

Prof Garcia-Manero hopes that the dogma of patient recruitment might be broached further with regulatory bodies, offering valuable learning opportunities to clinicians, and therapeutic options to otherwise discounted patients.

More coverage is available through ecancer news here.

ecancer's filming at ASH 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.